drugset / Trial / NCT01076842

Efficacy Evaluation of Different Medication Combination in Type 2 Diabetes Treatment

NCT01076842

Phase 4 Completed 75 enrolled Novo Nordisk A/S BodyMedia · collab
RandomizedParallel-groupOpen-labelTreatment

Summary

The purpose of this study is to compare the effectiveness of two different kinds of diabetes medications, insulin detemir (Levemir) and exenatide (Byetta), in improving blood sugar levels with little or no weight gain in patients with type 2 diabetes who are not well controlled on two or more oral (by mouth) diabetes medications. Both medications are given by injection with a very small needle just below the surface of your skin (called subcutaneous injection). The medication that you inject will be in addition to your oral medications.

Timeline

Start
2008-04
Primary completion
2011-04
Completion
2011-04

Drugs

EvaluationDrugModalityDoseRoute
Comparator Exenatide Peptide 10 ug Subcutaneous
Comparator insulin detemir Protein / enzyme biologic Subcutaneous